ALG-170675
/ Aligos Therap, Xiamen Amoytop Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 18, 2026
ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)
(clinicaltrials.gov)
- P1 | N=72 | Recruiting | Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Hepatitis B • Infectious Disease • Inflammation
August 04, 2026
ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)
(clinicaltrials.gov)
- P1 | N=72 | Not yet recruiting | Sponsor: Xiamen Amoytop Biotech Co., Ltd.
New P1 trial • Hepatitis B • Infectious Disease • Inflammation
1 to 2
Of
2
Go to page
1